Table of Contents

Articles

• You have access

  Metabolic Activation of Polycyclic Aromatic Hydrocarbons and Other Procarcinogens by Cytochromes P450 1A1 and P450 1B1 Allelic Variants and Other Human Cytochromes P450 in Salmonella typhimurium NM2009

  Tsutomu Shimada, Yoshimitsu Oda, Elizabeth M. J. Gillam, F. Peter Guengerich and Kiyoshi Inoue

  Drug Metabolism and Disposition September 2001, 29 (9) 1176-1182;
• You have access

  Simultaneous Pharmacokinetic Modeling of Cocaine and Its Metabolites, Norcocaine and Benzoylecgonine, after Intravenous and Oral Administration in Rats

  Lei Sun and Chyan E. Lau

  Drug Metabolism and Disposition September 2001, 29 (9) 1183-1189;
• You have access

  Mechanism-Based Inactivation of CYP2C11 by Diclofenac

  Yasuhiro Masubuchi, Atsushi Ose and Toshiharu Horie

  Drug Metabolism and Disposition September 2001, 29 (9) 1190-1195;
• You have access

  The Use of 3-[2-(N,N-Diethyl-N-methylammonium)ethyl]-7-methoxy-4-methylcoumarin (AMMC) as a Specific CYP2D6 Probe in Human Liver Microsomes

  Nathalie Chauret, Barry Dobbs, Rebecca L. Lackman, Kevin Bateman, Deborah A. Nicoll-Griffith, David M. Stresser, Joseph M. Ackermann, Stephanie D. Turner, Vaughn P. Miller and Charles L. Crespi

  Drug Metabolism and Disposition September 2001, 29 (9) 1196-1200;
• You have access

  Metabolism of Chlorpyrifos by Human Cytochrome P450 Isoforms and Human, Mouse, and Rat Liver Microsomes

  Jun Tang, Yan Cao, Randy L. Rose, Alan A. Brimfield, Diana Dai, Joyce A. Goldstein and Ernest Hodgson

  Drug Metabolism and Disposition September 2001, 29 (9) 1201-1204;
• You have access

  Genetic Polymorphism of Cytochrome P450 3A5 in Chinese

  Fang-Chun Chou, Shwu-Jen Tzeng and Jin-ding Huang

  Drug Metabolism and Disposition September 2001, 29 (9) 1205-1209;
• You have access

  Effect of α-Fluorination of Valproic Acid on Valproyl-S-Acyl-CoA Formation in Vivo in Rats

  Mark P. Grillo, Grazia Chiellini, Marco Tonelli and Leslie Z. Benet

  Drug Metabolism and Disposition September 2001, 29 (9) 1210-1215;
• You have access

  Metabolism of Vanoxerine, 1-[2-[bis(4-Fluorophenyl)methoxy]ethyl]-4-(3-phenylpropyl) Piperazine, by Human Cytochrome P450 Enzymes

  Svetlana A. Cherstniakova, Daoqin Bi, Daniel R. Fuller, Jurij Z. Mojsiak, Jerry M. Collins and Louis R. Cantilena

  Drug Metabolism and Disposition September 2001, 29 (9) 1216-1220;
• You have access

  Depentylation of the Rat Esophageal Carcinogen, Methyl-n-pentylnitrosamine, by Microsomes from Various Human and Rat Tissues and by Cytochrome P450 2A3

  Sheng Chong Chen, Lin Zhou, Xinxin Ding and Sidney S. Mirvish

  Drug Metabolism and Disposition September 2001, 29 (9) 1221-1228;
• You have access

  Induction of Cytochromes P450 1A1 and 1B1 by Emodin in Human Lung Adenocarcinoma Cell Line CL5

  Hui-Wu Wang, Ta-Liang Chen, Pan-Chyr Yang and Tzuu-Huei Ueng

  Drug Metabolism and Disposition September 2001, 29 (9) 1229-1235;
• You have access

  Role of Induction of Specific Hepatic Cytochrome P450 Isoforms in Epoxidation of 4-Vinylcyclohexene

  S. M. Fontaine, P. B. Hoyer, J. R. Halpert and I. G. Sipes

  Drug Metabolism and Disposition September 2001, 29 (9) 1236-1242;
• You have access

  Cytochrome P450 Induction in Rat Hepatocytes Assessed by Quantitative Real-Time Reverse-Transcription Polymerase Chain Reaction and the RNA Invasive Cleavage Assay

  Michael E. Burczynski, Michael McMillian, James B. Parker, Stewart Bryant, Angelique Leone, Elfrida R. Grant, Jacqueline M. Thorne, Zhong Zhong, Robert A. Zivin and Mark D. Johnson

  Drug Metabolism and Disposition September 2001, 29 (9) 1243-1250;